2010•Inner Mongolia Medical JournalRequires access

Comparative Study of Treatment Depression Between Fluvoxamine and Clomipramine

Liu Yong-yi

Open publisher page 0 citations

Abstract

Objective:Clinical efficacy and adverse reaction evaluation of fluvoxamine in treatment depression.Method:50 patients met the criterion of CCMD-3 for depression were assigned randomly to study group or control group treatment for 56 days.The efficacy was assessed by Hamilton Depression Scale(HAMD) and the adverse effects were assessed by Treatment Emergent Symptoms Scale(TESS).Laboratory tests included blood cell analysis,urinalysis,blood biochemical analysis and electrocardiogram.Result:The two groups clinical efficacy is similar treated 8 weeks,adverse reaction of fluvoxamine group less than clomipramine.Conclusion: Fluvoxamine is rather effective and lesser adverse reaction in treatment of depression.

About this research paper

What this paper is about

Objective:Clinical efficacy and adverse reaction evaluation of fluvoxamine in treatment depression.Method:50 patients met the criterion of CCMD-3 for depression were assigned randomly to study group or control group treatment for 56 days.The efficacy was assessed by Hamilton Depression Scale(HAMD) and the adverse effects were assessed by Treatment Emergent Symptoms Scale(TESS).Laboratory tests included blood cell analysis,urinalysis,blood biochemical analysis and electrocardiogram.Result:The two groups clinical efficacy is similar treated 8 weeks,adverse reaction of fluvoxamine group less than clomipramine.Conclusion: Fluvoxamine is rather effective and lesser adverse reaction in treatment of depression.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:Clinical efficacy and adverse reaction evaluation of fluvoxamine in treatment depression.Method:50 patients met the criterion of CCMD-3 for depression were assigned randomly to study group or control group treatment for 56 days.The efficacy was assessed by Hamilton Depression Scale(HAMD) and the adverse effects were assessed by Treatment Emergent Symptoms Scale(TESS).Laboratory tests included blood cell analysis,urinalysis,blood biochemical analysis and electrocardiogram.Result:The two groups clinical efficacy is similar treated 8 weeks,adverse reaction of fluvoxamine group less than clomipramine.Conclusion: Fluvoxamine is rather effective and lesser adverse reaction in treatment of depression.

Key concepts: Fluvoxamine, Medicine, Hamd, Clomipramine, Depression (economics), Adverse effect, Hamilton Rating Scale for Depression, Urinalysis

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparative Study of Treatment Depression Between Fluvoxamine and Clomipramine — Research Paper | ScholarLens